PharmiWeb.com - Global Pharma News & Resources

Articles

Creative Biolabs, a biopharmaceutical company focusing on antibodies services, introduces its antibody products targeted at research and development of diagnostic and therapeutic drugs for lung cancer(LC).
Creative Biolabs is working on lung cancer research related to antibody production and engineering with senior scientists and advanced research equipment. Integrin antibodies and p53 antibodies for Lung Cancer research are available. There are three main signaling pathways in breast cancer therapy. RTK signaling cascade. RTKs (Receptor tyrosine kinases) play an important role in the development and regulation of many carcinoid cells. Integrin-mediated signaling cascade. Integrins (ITGA/ITGB) are connectors of cell interaction that contribute to cell growth and mitogenesis. Growth in…
Antibody Prediction Services are available for the purposes of improving antibody developability prediction, antibody aggregation prediction, antibody immunogenicity prediction, etc. This paper gives detailed information about the services regarding advanced technologies and methods adopted.
About Creative Biolabs   Firstly started up at the beginning of 21 century in New York, USA, Creative Biolabs was set up by a group of biological scientists who are devoted to the development of antibodies. Aiming at facilitating drug or scientific research, high-tech antibody maturation platforms (i.e. PreciAb™), comprehensive antibody design services (i.e. Epitope-specific Antibody Design) and advanced technologies are provided. For more than 10 years of exploration and expansion, it is now regar…
This paper briefly describes the epitope-specific antibody design service provided by Creative Biolabs. With the most up to date 3-D antibody model and computer-aided affinity maturation methods, clients' needs can be met comprehensively.
In the field of <a href="https://www.creative-biolabs.com/preciab/#Our-Featured-Service">antibody design</a> services, Creative Biolabs has been regarded as the leading role after years of arduous exploration. Its products and services help customers accelerate the research process, solve complex problems and challenges encountered, promote the development of medical diagnosis, and improve laboratory productivity in the field of antibody science.   Reasons for choosing epitope-specific design services from Creative Biolabs are of sorts. Th…
Antibody drug conjugate (ADC) is a biologically active cytotoxic drug linked to a monoclonal antibody (mAb) by a chemical bond, and a monoclonal antibody (mAb) is used as a carrier to transport the cytotoxic drug to the target cells. This novel drug has brought a new trend in the field of cancer treatment and aroused interest of more and more people.
what is an antibody drug conjugate? Antibody drug conjugate (ADC) is a biologically active cytotoxic drug linked to a monoclonal antibody (mAb) by a chemical bond, and a monoclonal antibody (mAb) is used as a carrier to transport the cytotoxic drug to the target cells. This novel drug has brought a new trend in the field of cancer treatment and aroused interest of more and more people. So what are the features and history of ADCs and why are t…
For Labeling Challenges accordingly EU MDR introduces additional information that needs to be included on labels, forcing organizations to re-design the label templates.
The introduction of European Medical Device Regulation (EUMDR 2017/745) gives great importance to the end user to assist with the safe and proper use of a medical device(s). The EU MDR and other UDI-type of regulations is causing more and more medical device companies to revisit their labeling processes. EU MDR introduces additional information that needs to be included on labels, forcing organizations to re-design the label templates that make room for data not previously part of the labeling system. According to EU MDR..... “The medium, format, content, legibility, and location of the label and instructions for use shall…
Events are the second most significant investment for life sciences companies next to the field force. This article gives five tips on how intelligent and data-driven events management can make your events successful.
Events are the second most significant investment for life sciences companies next to the field force. By streamlining and automating the end-to-end events management process, you can ensure compliance, improve customer engagement, and better track return on investment.  Here are five tips on how intelligent and data-driven events management can make your events successful.  Leverage interaction data in your CRM Identify and select attendees and speakers based on a comprehensive range of data in your CRM, including past interactions and preferences. You can then use…
As demand for healthcare increases, the NHS can no longer rely on traditional models of care. Steve Bradley, Group Managing Director at Cegedim UK, discusses why Community Pharmacy is part of the solution and how the tools to integrate them are well within grasp.
The latest blueprint for the NHS in England vows to put community pharmacy at the heart of a new model of joined up care. The NHS Long Term Plan, published this January, outlines a vision for ‘fully integrated community-based healthcare’ where pharmacists play a prominent role in multidisciplinary teams aligned with new primary care networks. It’s an ambitious framework that finally gives community pharmacists a seat at the top table of NHS care. However, with opportunity comes challenge. Somehow, a profession that has for so long…
Pharmaceutical companies are increasingly using contract manufacturing organizations (CMO) to reduce overheads and overall costs, and speed up the drug development timelines. While outsourcing provides several advantages, it also presents many challenges.
1. The challenges Organizations that outsource do not have direct control over the CMO operations. Most of the CMOs deal with multiple clients and their manufacturing, laboratory, & quality systems are designed to allow them maximum flexibility. Additionally, there are different compliance/GMP philosophies. Companies that use CMOs are ultimately responsible for the product quality, safety, efficacy, and cGMP compliance. When issues at the CMOs are identified during audits, the organization that uses the CMOs receive warning letters and…
Beth Gaudin, Senior Consultant and Pharma Lead at Forster Communications, explores how pharma can create an engaged workforce.
An engaged and motivated workforce is near the top of the wish list for almost any employer. It improves turnover, sickness and presenteeism rates, and research has shown that companies with an engaged workforce outperform those without by a whopping 202%[1].   For many businesses, this ambition does not always meet up with the reality. Worldwide just 15% of employees are engaged with the work they do[2]. It’s a constant source of concern not just for HR teams, but for entire companies. No wonder then, that a recent survey found that for 40% of HR professionals thought employee engagement would be one of their biggest challenges for 2019[3].   Recruitment…
On 30 March, at the fourth annual Talking About Diabetes event, a host of celebrities, athletes, patients and healthcare professionals took to the stage to share their inspirational stories of living with and managing type 1 diabetes.
On 30 March, at the fourth annual Talking About Diabetes event, a host of celebrities, athletes, patients and healthcare professionals took to the stage to share their inspirational stories of living with and managing type 1 diabetes. Through a series of talks, the speakers provided fresh perspectives on living with type 1 diabetes, whilst experts in the area provided insights on the importance of removing barriers and embracing new technologies. Novo Nordisk UK is a key sponsor of the event, which took place at the Royal College of Physicians, London. Actor…
Regulatory Careers Live is the only one-day careers fair in Europe dedicated to regulatory affairs. Our careers fair is for anyone who is starting or looking to further their career in healthcare regulatory affairs no matter where they are in the profession. It is an opportunity to meet with potential future employers and get essential advice from some of the most respected and influential leaders in the field of regulatory affairs
21 May 2019 | University of Hertfordshire, Hatfield, UKRegulatory Careers Live is the only one-day careers fair in Europe dedicated to regulatory affairs. Our careers fair is for anyone who is starting or looking to further their career in healthcare regulatory affairs no matter where they are in the profession. It is an opportunity to meet with potential future…
Whatever the industry, digital transformation creates an opportunity for teams to connect to the fuller insights they need, on demand – which in turn can help to drive substantial improvements to productivity, accuracy and efficiency.
Whatever the industry, digital transformation creates an opportunity for teams to connect to the fuller insights they need, on demand – which in turn can help to drive substantial improvements to productivity, accuracy and efficiency. One of the main potential beneficiaries of improved information management in life sciences is Regulatory Affairs – a department which must prepare and manage data ad infinitum, to keep products on the market. Here, ProductLife Group’s Erick Gaussens sets out three persuasive reasons why RA teams should champion the digital trans…
Artificial intelligence (AI) is creation of unique systems using algorithms and software that can perform certain tasks without human intervention and instructions. Artificial intelligence comprises integration of several technologies such as machine learning, natural language processing, reasoning, and perception. Artificial intelligence is used in healthcare for approximation of human cognition and analysis of complex medical and diagnostic imaging data.
Artificial intelligence (AI) is creation of unique systems using algorithms and software that can perform certain tasks without human intervention and instructions. Artificial intelligence comprises integration of several technologies such as machine learning, natural language processing, reasoning, and perception. Artificial intelligence…
Cytomegalovirus treatment market, primarily based on off-label drugs prescription, is expected to grow rapidly in the coming years. Untapped opportunities for new companies to develop a technology solely for cytomegalovirus treatment spotted
A new study by the company, titled ' Cytomegalovirus Treatment Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028,' points out the key structural outlook for the cytomegalovirus treatment market. A large number of people are infected by Cytomegalovirus (CMV) virus during their life course, mostly in indications that are invasively treated like organ transplantation and stem cell transplantation. The virus is found active post treatment or later stages of any other treatment like mentioned before. Cytomegaloviruses are among…
PharmiWeb.jobs a new jobs board
PharmiWeb are very excited to be launch the new version of our world class Job Board PharmiWeb.jobs, as well as the latest Pharma News Portal PharmiWeb.com.To search for the best selections of Pharma Jobs in Europe visit pharmiweb.jobsTo find the widest range of pharma news, events and articles, search on this site! PharmiWeb are partnering with numerous providers and organisations such as: Jooble  To find our Jobs and other similar jobs please check  Jooble. Jooble is a job search engine operated in 70 countries worldwide.
The most technically advanced life sciences businesses know that in today’s world, digital innovation and platform hyper-connectivity are no longer a luxury. Technological innovations in clinical trials are increasingly necessary for enabling drug development. Life Sciences as an industry has an enormous opportunity to improve efficiency and cut costs, whilst extending the scope of its research and improving patient and clinical experiences.
The most technically advanced life sciences businesses know that in today’s world, digital innovation and platform hyper-connectivity are no longer a luxury. Technological innovations in clinical trials are increasingly necessary for enabling drug development. Life Sciences as an industry has an enormous opportunity to improve efficiency and cut costs,…
In its first ever pan European research on the life sciences industry, Kelly asked almost 1,400 of its workers their opinions on everything from work life design, to AI, through to what matters most to them. With respondents from Germany, France, the UK, Ireland, the Netherlands, Switzerland and Italy it was surprising to find so many commonalities between each of the countries.
The life sciences are all about diversity and movement, which is why Pharma and Medical Devices companies may need more than just a good reputation after Brexit. As the United Kingdom drifts towards an exit from the European Union, the Pharma and Medical Devices sectors are preparing for all eventualities. However, the employment landscape is already highly competitive and it is shifting. With a widespread skills sh…
Dr Rachael Benstead, senior aquatic ecotoxicologist at translational science and research organisation, Fera Science Ltd, looks at bioconcentration and biomagnification and what is being done to protect our planet.
The environment and the organisms living in it are continuously exposed to a wide range of chemicals. From chlorine-based solutions that remove bacteria from water to pesticides that treat and protect crops. However, through bioconcentration and the theory of biomagnification, some of these chemicals can become dangerous to our world. Here, Dr Rachael Benstead, senior aquatic ecotoxicologist at translational science and research organisation, Fera Science Ltd, looks at bioconcentration and biomagnification and what is being done to protect our planet. With every chemical produ…
Rachael Benstead, senior aquatic ecotoxicologist at Translational science and research organisation, Fera Science Ltd, helps plot a roadmap to a future in which we can take advantage of the benefits of nanotechnology in water and mitigate against the drawbacks.
It is entirely conceivable that the engineered nanoparticles that seem like today's water treatment panacea, could be tomorrow's ecological dynamite. The potential for the use of nanoparticles in water treatment such as water filtration is too compelling to ignore, despite the potential risks. Here, Rachael Benstead, senior aquatic ecotoxicologist at Translational science and research organisation, Fera Science Ltd, helps plot a roadmap to a future in which we can take advantage of the benefits of nanotechnology in water and mitigat…